Metastatic Prostate Cancer: Treatment Options
Metastatic Prostate Cancer: Treatment Options
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Background: Metastatic prostate cancer (PCa) is associated with considerable diminished overall survival (OS). Standard treatment for metastatic PCa has long been androgen deprivation therapy alone, with patients initially responding to this treatment and then progressing to a castration-resistant phase. Summary: The advent of novel therapeutic age...
Alternative Titles
Full title
Metastatic Prostate Cancer: Treatment Options
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1159_000519861
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000519861
Other Identifiers
ISSN
0030-2414
E-ISSN
1423-0232
DOI
10.1159/000519861
